Understanding cancer through advanced cell analysis techniques
Official title: Cytometry Shared Resource
Funded at University of Rochester · NIH-11014539 · Data updated 2026-11-12
This study is all about using special technology to look closely at different types of cancer cells, helping researchers understand how new treatments work and improve care for people with cancer.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | March 15, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $144,889 |
| NIH project number | 1P30CA272302-01A1 |
| Project ID | NIH-11014539 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with various types of cancer who may benefit from novel treatment approaches.
✕Less likely to help
Patients with non-cancerous conditions or those not seeking treatment for cancer may not receive any benefit from this research.
What this research studies
This research focuses on using flow cytometry to analyze and characterize different cell types involved in cancer. By providing researchers with access to advanced tools and expertise, the project aims to enhance the understanding of how novel treatments affect cancer cells and their biological processes. The Cytometry Shared Resource at the Wilmot Cancer Institute supports high-quality data collection and analysis, ensuring that findings are based on reliable measurements. This collaborative effort also includes developing new assays and analytical tools to further explore cancer biology.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatments and better understanding of cancer biology.
How similar studies have gone: Other research utilizing flow cytometry has shown success in advancing cancer treatment and understanding, indicating that this approach is well-established.
Where this research is happening
-
University of Rochester
Rochester, United States Active
Researchers
- Principal investigator: Bushnell, Timothy P — University of Rochester
- Study coordinator: Bushnell, Timothy P
Related research
Other NIH-funded projects on the same topics.
-
Rapid automated breast lump diagnosis without a radiologist or sonographer
A new AI-powered ultrasound tool helps determine if a palpable breast lump is likely benign or malignant, using a simplified technique that can be used by people with minimal ultrasound training.
-
ML-ROVER: Reducing Unneeded Lab Tests in Kids with AI
Aims to use machine learning to cut unnecessary blood tests in children in intensive care, helping avoid anemia and improve care quality.
-
Aggressive fever-reducing therapy to protect the brains of children with CNS malaria
A study planned for children with CNS malaria will test whether aggressive fever-reducing treatment can lower death and brain-related problems.
-
Aggressive fever-reducing therapy to protect brains in children with CNS malaria
A plan to test whether giving strong fever-reducing medications to children with central nervous system malaria can lower death and brain injury.
-
Aggressive fever-fighting treatment to protect the brain in kids with CNS malaria
A plan to test whether giving strong fever-reducing treatment alongside standard care can lower death and brain injury in children with CNS malaria.
-
Aggressive fever-reducing treatment to protect brains in kids with CNS malaria
A plan to test whether giving strong fever-reducing medicine alongside standard malaria treatment can lower deaths and brain injuries in children with CNS malaria.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.